FABP2 and metabolic syndrome: Thus, it remains to be established if this model can be assessed for the development of insulin resistance by studying GLUT4 transport at the liver or dyslipidemia by studying markers of lipid export (e.g., FABP2-4), both at liver and adipose tissues.